Form 13-F position report

CVS HEALTH CORP

Reported by FAIRFAX FINANCIAL HOLDINGS LTD CAN

CVS CUSIP 126650100 Manager CIK 0000915191

Reported 2,712,000 shares, unchanged from the prior quarter.

Reported value -17.1%; share count 0.0% vs. the prior quarter.

Unchanged
% of reported 13F value 8.78% This manager · Q3 2026
Shares 2,712,000 Quarter-end amount reported
Reported value $232,418,400 Fair value at quarter end
Consecutive quarters held 8 Through Q3 2026

Reported position value by quarter

Reported position value by quarter

Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.

Reported position value by quarter
Date Holding Value
2021-12-31 2733000
2022-03-31 2682000
2022-06-30 1390000
2022-09-30 1431000
2022-12-31 1397850
2023-03-31 1114500
2023-06-30 1036950
2023-09-30 1047450
2023-12-31 1184100
2024-03-31 1195950
2024-06-30 0
2024-12-31 121741680
2025-03-31 183765120
2025-06-30 186965280
2025-09-30 204376320
2025-12-31 215197200
2026-03-31 194775840
2026-06-30 280502160
2026-09-30 232418400

Quarterly position history

How this manager's reported quarter-end position changed over time.

19 quarters
Quarterly reported position history for CVS HEALTH CORP held by FAIRFAX FINANCIAL HOLDINGS LTD CAN.
Quarter Activity Shares Change % of reported 13F Reported value Filed Source filing
Q3 2026 Unchanged 2,712,000 0 (0.0%) 8.78% $232,418,400 2026-11-16
Q2 2026 Unchanged 2,712,000 0 (0.0%) 10.63% $280,502,160 2026-08-14
Q1 2026 Unchanged 2,712,000 0 (0.0%) 10.03% $194,775,840 2026-05-15
Q4 2025 Unchanged 2,712,000 0 (0.0%) 10.33% $215,197,200 2026-02-17
Q3 2025 Unchanged 2,712,000 0 (0.0%) 9.9% $204,376,320 2025-11-14
Q2 2025 Unchanged 2,712,000 0 (0.0%) 9.99% $186,965,280 2025-08-14
Q1 2025 Unchanged 2,712,000 0 (0.0%) 9.96% $183,765,120 2025-05-15
Q4 2024 New 2,712,000 +2,712,000 (0.0%) 7.82% $121,741,680 2025-02-14
Q2 2024 Reduced 0 -15,000 (-100.0%) 0 $0 2024-08-14
Q1 2024 Unchanged 15,000 0 (0.0%) 0.1% $1,195,950 2024-05-15
Q4 2023 Unchanged 15,000 0 (0.0%) 0.08% $1,184,100 2024-02-14
Q3 2023 Unchanged 15,000 0 (0.0%) 0.06% $1,047,450 2023-11-14
Q2 2023 Unchanged 15,000 0 (0.0%) 0.06% $1,036,950 2023-08-14
Q1 2023 Unchanged 15,000 0 (0.0%) 0.06% $1,114,500 2023-05-15
Q4 2022 Unchanged 15,000 0 (0.0%) 0.03% $1,397,850 2023-02-14
Q3 2022 Unchanged 15,000 0 (0.0%) 0.04% $1,431,000 2022-11-14
Q2 2022 Reduced 15,000 -11,500 (-43.4%) 0.05% $1,390,000 2022-08-15
Q1 2022 Unchanged 26,500 0 (0.0%) 0.09% $2,682,000 2022-05-16
Q4 2021 Unchanged 26,500 0 (0.0%) 0.09% $2,733,000 2022-02-14
Five years are shown. A free account unlocks the complete reported history. Unlock full history

Who else reported the position

2186 managers reported CVS HEALTH CORP for Q3 2026.

Managers reporting CVS HEALTH CORP in Q3 2026.
Manager Activity Shares Change % of reported 13F Reported value Tenure
BlackRock Inc Reduced 120,390,157 -2,833,252 0.15% $10,316,232,599 9 qtrs
VANGUARD CAPITAL MANAGEMENT LLC Added 83,686,369 +371,000 0.15% $7,171,084,960 3 qtrs
Capital World Investors Reduced 74,043,290 -908,665 0.77% $6,345,353,959 29 qtrs
STATE STREET CORPORATION Reduced 60,087,270 -196,138 0.15% $5,148,878,166 54 qtrs
Dodge & Cox Reduced 46,041,525 -3,971,240 2.11% $3,945,298,277 33 qtrs
WELLINGTON MANAGEMENT GROUP LLP Added 36,682,829 +2,881,716 0.56% $3,143,351,616 54 qtrs
GEODE CAPITAL MANAGEMENT LLC Added 30,921,045 +1,021,392 0.14% $2,638,142,619 54 qtrs
VANGUARD PORTFOLIO MANAGEMENT LLC Added 27,110,307 +473,048 0.1% $2,323,082,207 3 qtrs
FMR LLC Reduced 24,881,207 -4,039,410 0.09% $2,132,070,581 54 qtrs
Bank of America Corporation Added 23,615,565 +426,895 0.13% $2,023,617,839 54 qtrs
Premium adds each manager's conviction percentile across reporting peers.
Filing details and methodology As reported
Report period
September 30, 2026
Filed
November 16, 2026
Filing type
13F-HR
Position type
COM

Voting authority reported

Sole
2,712,000
Shared
0
None
0

“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.

Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.